Based on the CRL, the STARGLO data do not provide sufficient evidence to support the proposed second-line DLBCL indication in the US patient population
Vimta Labs has reported total income of Rs. 99.31 crores during the period ended June 30, 2025
Loteprednol Etabonate Ophthalmic Suspension, 0.5% is indicated for the treatment of steroidresponsive inflammatory conditions of the palpebral and bulbar conjunctiva
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations
The Stryker Mako Robotic System uses artificial intelligence to improve surgical accuracy with real-time guidance, personalized planning, and precise execution
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
Loteprednol Etabonate Ophthalmic Gel, 0.38% is a corticosteroid indicated for the treatment of postoperative inflammation and pain following ocular surgery
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
25 women students to receive internship, training, and mentorship in Life Sciences segment
Annual EBITDA margin expands by 170 basis points
Subscribe To Our Newsletter & Stay Updated
